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Abstract
Background: Tissue differentiation is accompanied by genome-wide changes in the underlying chromatin
structure and dynamics, or epigenome. By controlling when, where, and what regulatory factors have access to the
underlying genomic DNA, the epigenome influences the cell’s transcriptome and ultimately its function. Existing
genomic methods for analyzing cell-type-specific changes in chromatin generally involve two elements: (i) a source
for purified cells (or nuclei) of distinct types, and (ii) a specific treatment that partitions or degrades chromatin by
activity or structural features. For many cell types of great interest, such assays are limited by our inability to isolate
the relevant cell populations in an organism or complex tissue containing an intertwined mixture of other cells.
This limitation has confined available knowledge of chromatin dynamics to a narrow range of biological systems
(cell types that can be sorted/separated/dissected in large numbers and tissue culture models) or to
amalgamations of diverse cell types (tissue chunks, whole organisms).
Results: Transgene-driven expression of DNA/chromatin modifying enzymes provides one opportunity to query
chromatin structures in expression-defined cell subsets. In this work we combine in vivo expression of a bacterial
DNA adenine methyltransferase (DAM) with high throughput sequencing to sample tissue-specific chromatin
accessibility on a genome-wide scale. We have applied the method (DALEC: Direct Asymmetric Ligation End
Capture) towards mapping a cell-type-specific view of genome accessibility as a function of differentiated state.
Taking advantage of C. elegans strains expressing the DAM enzyme in diverse tissues (body wall muscle, gut, and
hypodermis), our efforts yield a genome-wide dataset measuring chromatin accessibility at each of 538,000 DAM
target sites in the C. elegans (diploid) genome.
Conclusions: Validating the DALEC mapping results, we observe a strong association between observed coverage
by nucleosomes and low DAM accessibility. Strikingly, we observed no extended regions of inaccessible chromatin
for any of the tissues examined. These results are consistent with “local choreography” models in which differential
gene expression is driven by intricate local rearrangements of chromatin structure rather than gross impenetrability
of large chromosomal regions.
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Recent advances in sequencing technology have allowed
experimentalists a global view of the relationship
between chromatin structure and genomic activity dur-
ing development. By combining chromatin immunopre-
cipitation (ChIP) with high throughput sequencing or
DNA microarrays (ChIP-Seq or ChIP-chip), it is possible
to query the genomic localizations of specific transcrip-
tion factors, histone modifications, and chromatin remo-
delling factors. Chromatin state maps from ChIP-Seq
and ChIP-chip experiments along with data from gen-
ome-wide nuclease accessibility studies can be used to
define molecular landscapes (including transcription
start sites, regions of active transcription, enhancers,
euchromatin, heterochromatin, etc.) on a genome-wide
scale. Implicit in this analysis is the assumption that a
cell’s chromatin signature, or its epigenome, will be
highly diagnostic of function.
One metric of chromatin structure is accessibility of the
DNA in bulk chromatin. DNA-modifying enzymes such as
nucleases [1,2] and methyltransferases [3-5] have proven
to be useful tools for defining susceptible regions. Accessi-
ble DNA may in some cases define regions of “open chro-
matin” that allow access to DNA binding factors such as
transcription factors. In contrast, less accessible DNA may
define regions of relatively compact chromatin and is
often characterized by transcriptional inactivity.
Cleavage of chromatin by micrococcal nuclease
(MNase) has been a standard method for examining
nucleosome positioning and regional accessibility, both
in vitro and in situ [6,7]. Despite the substantial infor-
mation that can come from MNase studies, this enzyme
is known to have specific sequence and structural pre-
ferences [8-10], generating a well-recognized need for
additional reagents and methods to independently sur-
vey genome accessibility. Several alternative nuclease or
other approaches have been used for localized studies of
accessibility [2,11-15], each has its own potential advan-
tages and potential biases.
One limitation of available methods for genomewide
analysis of chromatin structures in specific cell types has
been the need to isolate the individual cell type of inter-
est in considerable bulk. Epigenome characterization
methods using nucleases and other destructive probes
have thus been applied only in the narrow range of bio-
logical systems where individual cell types can be iso-
lated (or in whole organisms or mixed-cell-type tissues,
where the results represent an amalgamation of the
numerous constituent cell types). For many of the most
interesting biological questions, the cell groups of inter-
est are surrounded by (and embedded in) other very dif-
ferent cell types, making uniform-cell-type preparations
impossible on the scale currently needed for genome-
w i d ea n a l y s i s .A so n em e a n so fa d d r e s s i n gt h i sc h a l -
lenge, transgene-driven expression can be used to pro-
duce a specific probe in a defined cell type. This type of
approach requires a probe that can detectably modify
chromatin or DNA without killing or substantially dis-
turbing the relevant cells.
DNA adenine methyltransferase (DAM) catalyzes the
addition of a methyl group to the adenine base in the
sequence GATC [16]. DAM activities are used by a num-
ber of bacterial phages and prokaryotes. In E. coli,D A Mi s
involved in a multitude of cellular processes, including
DNA replication, mismatch repair, control of gene expres-
sion, and restriction-modification immunity [17,18].
DAM from E. coli has been used to analyze chromatin
structure in eukaryotic cells [19-21] and there is good
localized agreement between chromatin structure
inferred using DAM and other techniques, such as
nuclease hypersensitivity mapping [4,22]. Importantly,
sensitivity to DAM methylation correlates well with
transcriptional activity [23-25]. These results support
the use of susceptibility to DAM methylation as a mea-
sure of chromatin structure. Key advantages of using
DAM to probe eukaryotic chromatin structure are (i)
the ability to assay accessibility in a living cell, (ii) the
ability to assay designated sets of cells or tissues in com-
plex biological samples using transgenes with regulated
promoters, and (iii) the lack of any known background
of DAM activity in eukaryotes. The addition of 6-methyl
adenosines at sites in eukaryotic genome is apparently
well tolerated in a variety of tissues, as functional
expression of DAM methyltransferase in yeast, Droso-
phila, and mammalian cells has not resulted in any
apparent phenotypes [5,19,22,26,27].
Previous studies of chromatin structure using DAM
were limited to the investigation of only a few loci due
to the low throughput nature of Southern blotting
experiments. In this article, we describe a method that
couples DAM methylation to high throughput sequen-
cing. We termed our method DALEC and applied it to
investigate in vivo chromatin structure in three trans-
genic C. elegans strains, each expressing DAM from a
tissue-specific promoter. We provide evidence that genic
regions remain in an accessible state that can be probed
with DAM activity even when not expressed, with fea-
tures of chromatin structure inferred from DAM acces-
sibility concordant with nucleosome positioning and
expression data derived from independent sources.
Results
Engineering E. coli dam methyltransferase for expression
in C. elegans
We first adapted the E. coli dam gene coding region for
expression in C. elegans.W e ’ve previously found that
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improve expression of transgenes in C. elegans [28]. The
dam gene was cloned by PCR from E. coli strain OP50.
Two introns were incorporated at blunt cutting restric-
tion sites (Additional File 1, Figure S1). Two myo-3 pro-
moter constructs driving dam were produced. In
pPD177.01, DAM was designed to express as a fusion to
GFP; while in pPD176.59, a nuclear localization signal
(NLS) from SV40 was included. Each construct was
then incorporated into transgenic strains using pha-1(+)
as a selectable genetic marker in a pha-1(e2123ts)
genetic background [29]. The two resulting transgenic
lines were designated PD3994 (harboring pPD176.59)
and PD5122 (harboring pPD177.01).
Both transgenic lines exhibited slightly slower move-
ment and growth than wildtype animals; these effects
were subtle, confounding any determination of whether
this was due to the rescued pha-1(e2123ts) genetic back-
ground and/or expression of the methyltransferase. To
assess tissue specificity of DAM expression, we exam-
ined PD5122 under fluorescence microscopy (Figure 1).
When the animal is oriented laterally as in Figure 1a,
the body wall muscles run along the animal’s dorsal and
ventral axes. A view from the animal’sd o r s a la x i si s
shown in Figure 1b. In addition to body wall muscles,
myo-3 is also expressed in the vulval muscles [28,30],
easily identified as an “X” in the animal’s ventral surface
(Figure 1c, arrow). Within the body musculature, there
is some degree of mosaicism in transgene expression in
these animals. For example, notice in Figure 1c that cer-
tain body wall muscle cells (to the right and below the
“X”) lack GFP, possibly due to loss of expression or of
the extra-chromosomal transgene array. We also note
the presence of small GFP-positive granules in all these
muscle cells (Figure 1d). We do not know the identity
of these punctate structures, but we do not think they
a r em i t o c h o n d r i a ,a st h e r ea r ef a rm o r em i t o c h o n d r i a
that take up targeted GFP in C. elegans body wall mus-
cle cells than what is seen in these pictures [31]. Since
the DAM-GFP fusion used in PD5122 does not contain
a characterized NLS, we were initially unsure whether
the fusion protein would have access to the nucleus. As
is evident in Figure 1d, not only did the methyltransfer-
ase have access to the nucleus, it appears to be predomi-
nantly found in the nucleus. Hypodermis-specific
DAM-GFP expression from the rol-6 promoter (line
PD3995) and gut-specific expression of DAM-GFP from
the vit-2 promoter (line PD3997) are also evident
(Figure 1 e,f and 1g,h). Together, these observations
indicate that DAM can be engineered to express in a
tissue-specific manner and that its localization to the
nucleus can apparently occur without a NLS.
DAM methyltransferase is active in C. elegans
To assess the patterns of DAM methylation in trans-
genic animals, we used a combination of isoschizomer
restriction enzymes that are differentially sensitive to
GATC methylation. Dpn I cuts only GATC sites
Figure 1 Promoter specific expression of DAM methyltransferase in transgenic animals. (a-d) PD5122 animals expressing DAM-GFP fusion
driven by the myo-3 (body wall muscle) promoter. (a = L4,10X; b = adult,10X; c = adult,10X; d = adult,100X). (e-f) PD3995 animals expressing a
DAM-GFP fusion construct driven by the rol-6 (hypodermal) promoter. (e = 200X; f = 400X). (g-h) PD3997 animals expressing a DAM-GFP
construct driven by the vit-2 (gut) promoter. (g = 200X; h = 200X)
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methylated GATC and Sau3A I cuts both methylated
and non-methylated sites. Genomic DNA samples from
wildtype (N2), PD3994, and PD5122 transgenic animals
were digested with each restriction enzyme and probed
with an ≈808 bp probe from the C. elegans 5S/SL1
rDNA locus. The 5S/SL1 cluster consists of about 110
copies of a 1 kb repeat and generally has high transcrip-
tional activity [32,33]. Southern blot analyses showed
that the methylation status of the two DAM-expressing
transgenic lines differed from that of the wildtype con-
trols. The PD3994 and PD5122 lanes showed a strong
Figure 2 Copy number determination for lines PD3994 and PD5122.P a n e l sa ,c ,e ,g ,a n dia r ea g a r o s eg e li m a g e so fDpn I, Mbo I,a n d
Sau3A I digested DNA from PD3994, PD5122, and N2 (control) animals. Below each agarose gel is the corresponding Southern blot (b, d, f, h, j).
pPD98.38 is a plasmid from which the probe (808 bp of the C. elegans 5S rDNA/SL1) was synthesized. The slight smearing seen in ethidium
bromide stained gels for N2 (a and e) likely resulted from non specific activity of Dpn I. Compared to fully methylated GATC, Dpn I can cut non-
methylated GATC 1,000 fold slower and hemimethylated GATC 60 fold slower (Derek Robinson, New England Biolabs, personal communication).
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methylated DNA substrates were available for Dpn I
restriction (Figure 2a,e). The smearing in the N2(OP50)
lane in Figure 2e was likely due to E. coli(OP50) DNA
from the animals’ digestive tracts. Because the OP50
strain of E. coli carries the wildtype dam gene, its DNA
is a substrate for Dpn I restriction.
The difference between DAM exposed and non-
exposed DNA was clear in the corresponding Southern
blots. Distinct Dpn I cleavage bands that were present
in the PD3994 (Figure 2b) and PD5122 (Figure 2f) lanes
were absent from the N2 lanes. An important feature of
these gels is the appearance of bands indicative of
incomplete digestion of individual fragments by Dpn I.
Such bands were reproducibly observed in digestions of
DNA from DAM-expressing lines (Figure 2b,f and data
not shown), consistent with DAM modification of a sub-
set (and not all) GATC sites in any given chromosomal
molecule.
Restriction by Mbo I likewise revealed differences
between DAM-exposed and wildtype DNAs. On bulk
ethidium staining, genomic DNAs from PD3994 (Figure
2c, arrow) and PD5122 (Figure 2g, arrow) were left
uncut by Mbo I compared to N2 DNA. The presence of
considerable levels of digested DNA (smears in the agar-
ose gels for PD3994 and PD5122) can be explained by
the fact that the transgene arrays (ccEx3994 and
ccEx5122) a r ed r i v e nb yam u s c l ep r o m o t e ra n d
expressed only in muscle cells; non-muscle tissues
(comprising about 90% of the body mass) would have
been substrates for Mbo I restriction. In the Southern
blots for Mbo I digests, (Figure 2d,h), wildtype DNA
was essentially completely digested while DNA from
transgenic animals were only partially digested. The
unrestricted and partially restricted DNA (Figure 2d,h,
arrows) would be expected to represent methylated
DNA from muscle tissue. The ability of Sau3A I to cut
GATC irrespective of DAM methylation provided a con-
trol for DNA quality and restrictability. As expected,
identical Sau3A I patterns were observed in wildtype
and DAM-expressing strains (compare Sau3A I lanes in
Figs. 2c versus 2d, and 2i versus 2j). In combination, the
Southern blot analysis demonstrates the ability of
expressed DAM to modify the C. elegans genome in an
extensive but limited manner.
We next carried out a pilot mapping of DAM methy-
lation by conventional cloning and sequencing of Dpn I
products. Each cloned fragment would have been
expected to carry full methylation at both ends, with no
methylation or hemi-methylation of intervening GATC
sites which were not cleaved (Additional File 2, Figure
S2). As a control, the cloning protocol was performed in
parallel on wild type C. elegans DNA. Only small num-
bers of clones were recovered in this case, all derived
from bacteria sequences or lacking the characteristic
Dpn I-cleaved ends (data not shown). By contrast, large
numbers of clones could be obtained from PD3994 and
PD5122: 335 non-redundant Dpn I fragments were char-
acterized from these (168 from PD3994 and 167 from
PD5122), of which 314 had termini derived from Dpn I
cleavage at methylated GATC sites (Additional File 2,
Table S1). These sequences were distributed throughout
the genome (Additional File 2, Figure S3) and spanned
exons, introns, exon-intron junctions, and non-anno-
tated (intergenic) regions (Additional File 2, Tables S2
and S3). In addition to the genomic distribution, it was
of interest to observe fragments from muscle-expressed
and non-muscle expressed genes (Additional File 2,
Tables S4 and S5).
Profiling genome-wide chromatin accessibility using
Direct Asymmetric Ligation End Capture (DALEC)
To obtain a genome-level view of chromatin susceptibil-
ity to DAM methylation, we developed a method that
captures sequences flanking methylated GATC sites for
high throughput sequencing (Figure 3). Genomic DNA
from transgenic animals expressing tissue-specific DAM
is digested with Dpn I. The resulting blunt-ended Dpn I
product is captured by ligation to a branched linker
("A”, inset) containing an asymmetric restriction site
(Mme I) adjacent to the site of ligation. Mme I cleavage
of these ligation products liberates a population of frag-
ments containing ≈20 bp of C. elegans DNA with a two
nucleotide 3” overhang (Step 3 product). The Mme I
product is ligated to a second branched linker ("B”,
inset), consisting of a pool of 16 different species of
molecules that differ only at the 3” two nucleotide over-
hang. The top strand (116 nucleotides long) of the
resulting doubly-linkered molecule is separated from the
bottom strand (71 nucleotides long) using denaturing
polyacrylamide gel electrophoresis and amplified by PCR
using Solexa bridge amplification primers [5′-AATGA-
TACGGCGACCACCGA-3′,5 ′-CAAGCAGAAGACGG-
CATACGA-3′]. To achieve quantitative results, we
titrated the PCR reactions to ensure amplification in the
linear range. In our experience, typically 11-15 cycles
are sufficient. The appearance of a band migrating at or
near 125 bp (in addition to the 116 bp band) is diagnos-
tic of over-amplification. The PCR product is electro-
phoresced in a 3% low melting point agarose gel (i.e.
NuSieve™) and the 116 bp band excised and purified.
The 116 bp amplicon is directly sequenceable on the
Illumina platform. (See Additional File 2 Methods sec-
tion for additional notes on DALEC assay).
We constructed and sequenced libraries from animals
expressing myo-3::dam (PD3994, muscle), rol-6::dam-
GFP (PD3995, hypodermis) and vit-2::dam-GFP
(PD3997, gut), with a control library from N2 DNA
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Page 5 of 15Figure 3 Schematic of DALEC. Brown and green represent priming regions for Solexa bridge amplification primers. Blue indicates the primer
binding region for the Solexa sequencing reaction. TCCGAC is the Mme I recognition sequence and the sequence immediately upstream of it
(black) is the variable region. The inset gives detailed information for linkers A and B.
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were staged to maximize the mass of the tissue expres-
sing the DAM protein (L1 for muscle; L4 and young
adults for hypodermis; adults for gut). A combined total
of 28.1 million raw reads were obtained from two sepa-
rate sequencing runs. Linker sequences could be suc-
cessfully parsed out from 25,319,003 reads. We
considered a parsing event successful if the resulting
product had the structure 5′-N16-19GA-3′. Parsed read-
outs were in turn converted to a 16 nucleotide format
containing only the 16 nucleotides immediately
upstream of the 3′ GA. Parsed tags were then mapped
to a database containing all filtered DAM tags in the C.
elegans WS170 genome. A “hit” was considered only if
there was a 16 nucleotide perfect match between the
Solexa readout and the in silico-generated tag. Since
each 16 nt tag in the database actually represented a
molecule of the structure 5-(N)16GATC-3′, our criterion
in actuality required a 20 nt perfect match. In total,
11,229,470 reads could be aligned to the genome. After
exclusion of repetitive and “proximal” tags (see Addi-
tional File 2, Figure S4 for definition and filtering of
“proximal” tags), we obtained 9,651,128 tags that aligned
uniquely to the genome, representing an average of 9-
fold coverage (per GATC site in the diploid genome).
These were used for all analyses described below.
Relationship between expression and DAM accessibility
The analysis of DAM-DALEC data for different tissues
provides an opportunity to characterize the relationship
between gene activity and DAM accessibility. We first
compared total numbers of DAM “hits” between indivi-
dual genes in pairs of samples from the analysis. Raw
tag numbers for each gene in any two data sets were
used as X and Y values to place a point on a graph, so
that a neutral situation in which tags were equivalently
distributed between samples would produce points
along a straight line. A striking feature of this analysis
was the remarkable concordance between samples in
representation of tags for individual genes (Figure 4).
Despite the tissue-restricted expression of many genes
in these individual tissues [34], a significant deviation in
overall DAM accessibility was essentially limited to a
two-fold range. As a control, we examined DNA seg-
ments present in the transgene constructs (and thus at
higher copy numbers) in the individual lines; this analy-
sis showed the expected substantial differences in tag
representation between samples (data not shown). A
similar comparison for functional partitions of the gen-
ome (introns, exons, and sequences flanking the anno-
tated gene boundary) is presented in Additional File 2,
Figure S5. As with the gene-by-gene comparisons, we
did not observe regions with a greater than two-fold
deviation from the mean for the genome.
Despite the lack of large deviations from a mean
accessibility, we do observe genes and genomic seg-
ments with some significant deviation from the mean in
their tag representation in individual samples. To deter-
mine potential relationships between variations in acces-
sibility and expression, we compared accessibility indices
as a function of gene representation in a filtered SAGE
dataset (Figure 5; see Materials and Methods section for
SAGE filtering parameters and analysis methodology).
Notably, the magnitudes of the differences are rather
modest (less than 1.25-fold). Nonetheless, this analysis
shows a reproducible positive correlation between aver-
age DAM accessibility and gene expression for all three
transgenic lines.
A periodic DAM accessibility profile that correlates with
nucleosome positioning at promoters
To characterize chromatin structure and accessibility on
a subgenic level, we compared DAM methylation profile
with previously published nucleosome position datasets
for C. elegans. Of particular interest are datasets of total
nucleosome positioning [35] and those in which a
nucleosomal population was enriched for active chroma-
tin by immunoprecipitation using antibodies to modified
histones, in particular methylation on lysine 4 of histone
H3 [36]. The H3K4me2/3 nucleosome occurs at the 5′
end of actively expressed genes and displays a high
degree of constraint and phasing characteristics of its
positioning, with bulk nucleosomes showing a much
lower degree of reproducibility in positioning [35]. A
prominent “peak” H3K4me2/3 nucleosome can be read-
ily detected at the 5′ end of 3,904 genes, the majority of
which are house-keeping genes (e.g. ribosomal proteins).
To represent the relationship between nucleosome posi-
tion and DAM accessibility, we calculated n numbers of
DAM tags each position (relative to the peak dyad, nor-
malizing to the number of DAM sites at the same posi-
tion). A signal in this analysis depends on significant
local positioning of nucleosomes, and not surprisingly
we obtained little signal with the less-positioned bulk
nucleosomes (data not shown).
For the H3K4 methylated nucleosomes, we saw a dis-
tinctive pattern (Figure 6), with the overall DAM methyla-
tion levels oscillating between a valley at a nucleosome
dyad position and a peak at linker region. The concor-
dance is especially strong for muscle (pink) and gut
(green). The somewhat low concordance for hypodermal
(blue) is most likely the result of low tag representation
(due to less input DNA for library preparation). The same
analysis on the control in vitro modified genomic DNA
displayed a profile that was essentially flat. This result is
consistent with the preference of linker DNA over nucleo-
some core DNA for DAM methylation. As an independent
probe, DAM methylation confirms the nucleosome
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ized by using micrococcal nuclease digestion.
Regions that are upstream to the H3K4me2/3 peak
nucleosomes have been found to display a low level of
observed nucleosome coverage. Correspondingly, the
overall DAM methylation level is higher in regions
upstream than in regions downstream to the H3K4me2/
3 peak nucleosome.
Nucleosome coverage at ≈150bp upstream (“NDR” in
Figure 6) to the dyad of the H3K4me2/3 peak nucleo-
some has a lowest level. If DNA in this region tends to
be in an unprotected state, one would expect to observe
a high level of DAM accessibility. Instead, there is a val-
ley at this position for DAM methylation profiles from
all three tissues. This result suggests that DNA in this
region is protected by additional factors.
Figure 4 Minimal global inaccessibility of inactive genes in differentiated tissues. Each point represents a gene. The X and Y axes indicate
promoter-specific DAM accessibility across the two tissues being compared. The bottom right panel is the comparison between in vitro
methylated N2 DNA versus DAM-exposed DNA from muscle tissue. The black line is normalized equivalence; while the blue curves demarcate
the level of divergence that is (1) at least two-fold, and (2) statistically significant to P < 0.05.
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Page 8 of 15Figure 5 DAM accessibility correlates with SAGE expression levels. X-axis indicates SAGE scores (i.e. SAGE hit counts). Y-axis indicates DAM
accessibility index (ratio of tissue-specific DAM hits normalized over control genomic DNA DAM hits). Only tags that had at least four hit half
sites (where each half site must have been hit at least once for any one of the tissue samples myo-3, rol-6, vit-2, and genomic DNA control) were
used in the analysis. Following a calculation for each sample of the average number of hits per GATC site (using the tags’“ txStart” and “txEnd”
from the UCSC genome browser version WS170), the final DAM accessibility index for a particular tissue was determined by normalizing average
hits per GATC to that observed for the in vitro DAM treated C. elegans genomic DNA control. Each point represents the average of the
accessibility indices of all genes that have the same SAGE score. The “9+” category represents the aggregate average of all DAM accessibility
indices with SAGE scores greater than 9.
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In this article, we presented our study of chromatin
structure in differentiated C. elegans tissues by measur-
ing DNA accessibility in living animals. To examine a
series of in vivo accessibility profiles, we expressed dam
driven by three tissue-specific promoters (myo-3, rol-6,
vit-2) and analyzed the methylation profile of synchro-
nized animal populations. Such an analysis would be
expected to identify both dramatic and subtle differences
in in vivo accessibility. Somewhat surprisingly given a
number of models for developmental regulation that
involve higher order inaccessibility of large regions of
chromatin [37], we observed no genes or regions which
were completely inaccessible to DAM modification in
vivo. In particular, no region or gene showed a deviation
in accessibility that was greater than from the genome-
wide average. Analysis of quantitative differences in
DAM accessibility does reveal correlations, particularly
showing a relationship between accessibility and expres-
sion levels: with increasing SAGE representation
numbers, we observe a corresponding increase in acces-
sibility over many genes and in all samples and tissues
analyzed. Because SAGE measures expression by captur-
ing the pool of mature mRNAs, our results suggest that
DAM accessibility at least partially reflects average tran-
scriptional activity.
Although the data argue against “open/shut” accessi-
bility versus inaccessibility of non-expressed chromoso-
mal domains during development, there is certainly
evidence for stable structures that protect specific
sequences for extended time periods. These are evi-
denced by the capture of Dpn I fragments with internal
(non-methylated) GATC sites (Additional File 2, Figure
S2 and Table S1). These internal sites would have been
protected from DAM methylation for an extended per-
iod while DAM was expressed in the relevant cells.
We observed very strong correlation between DAM
accessibility and nucleosome positioning, in agreement
with previous work [4]. As shown in Figure 6, DAM
accessibility peaks at inter-nucleosomal regions,
Figure 6 DAM accessibility correlates with nucleosome positions. This figure shows the superimposition of average DAM accessibility versus
average MNase accessibility around the transcription start site (TSS) of 3,904 strongly expressed C. elegans genes. The dotted red curve
represents a moving average of the muscle profile with a sliding window of 400 nucleotides. Positioned H3K4me2/3 nucleosomes are
represented by ovals above the picture of the generic gene. Numbers on the nucleosomes indicate their positions relative to the TSS.
[NDR = nucleosome depleted region]
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nucleosomes become less uniform in position (beyond
500 bp upstream and downstream of the TSS), the peri-
odicity in DAM methylation profile is decreased.
Our results provide support for DAM-DALEC and
nucleosome ChIP-Seq [36,38] as complementary tech-
nologies in establishing and validating detailed chroma-
tin maps. Certainly ChIP-Seq provides the highest
resolution maps for chromatin; at the same time this
technique is limited by the need for extensive
processing of samples after chromatin extraction. DAM-
DALEC provides an in vivo picture of chromatin
structure that is unaffected by concerns of specificity
and rearrangement on extraction but is lower resolution
in terms of the numbers of sites analyzed. Certainly the
combination of the two methods will be of value in
defining both static architecture and developmental
shifts.
Conclusions
We have developed an assay with the capacity to infer
chromatin structure on a genome level in living organ-
i s m s .W eh a v es h o w ni t sc o n cordance to gene expres-
sion and positioned nucleosome data obtained from
independent sources. Thus, DAM-DALEC can provide
independent high-confidence in vivo data, which even
for a fraction of the genome can be used to refine, vali-
date, or evaluate less sparse but potentially more ‘inva-
sive’ nuclease-based assays. DALEC could readily be
adapted to any context in which expression of foreign
coding regions (dam methyltransferase) can be engi-
neered. Because eukaryotes do not possess an adenine
methylation system, the enzyme would have a possibility
of being “neutral” to the host cell and not subject to
regulation. Thus, DAM-DALEC could offer an advan-
tage of capturing snapshots of chromatin structure in
living animals at defined developmental stages and can
be a powerful tool that complements existing genomics
methods for investigating chromatin structure and
dynamics on a whole genome level.
Methods
C. elegans strains and growth conditions
Animals were reared on E. coli g r o w no nN G M( n e m a -
tode growth medium) nutrient plates [39]. Bacterial
strains used in this work as food for C. elegans are
noted for each experiment.
OP50 [39]: A uracil-auxotrophic E. coli strain with
wild-type dam and dcm methylation systems. This strain
has been a standard laboratory food source for C.
elegans.
SCS110: An E. coli strain defective in both dcm and
dam methylation: rpsL (Str
r) thr leu endA thi-1 lacY
galK galT ara tonA tsx dam dcm supE44D (lac-proAB)
[F’ traD36 proAB lacI
qZDM15]. This strain provides a
suitable food source for C. elegans while avoiding the
presence of bacterial sequences with adenine methyla-
tion in eventual sequencing libraries.
SCS110(Amp
R): SCS110 made ampicillin resistant by
transformation with pUC18. This strain adds the ability
to “switch” bacterial food sources in a culture by cultiva-
tion of previously OP50-fed populations with SCS110
(AmpR)
+ and ampicillin.
All worm strains were reared at 23°C unless otherwise
stated. C. elegans strains used in the experiments were
as follows:
N2: wildtype strain of C. elegans (Bristol isolate)[39]
PD5122 [pha-1(e2123ts)I I I ;ccEx5122]: transgenic
line expressing E. coli dam-GFP translational fusion and
genomic C. elegans pha-1(+) gene from the extra-chro-
mosomal array ccEX5122. Line PD5122 was established
by microinjection of a mixture of plasmids pPD177.01
(Lig6682) and pC1 into pha-1(e2123ts)a n i m a l s .
pPD177.01 contains the myo-3 (body wall muscle) pro-
moter driving E. coli dam f u s e dt oG F P .T w oi n t r o n s
with C. elegans consensus sequences have been inserted
into the dam gene to optimize expression in nematodes
[28,40]. A detailed description of pPD177.01 structure is
shown in Additional File 1, Figure S1. pC1 carries the
wildtype pha-1 coding region; non-transformed pha-1
(e2123ts) animals are inviable at 23°C, while transformed
animals carrying pC1 are viable, providing a strong
selection [29].
PD3994 [pha-1(e2123ts)I I I ;ccEx3994]: transgenic
line expressing E. coli dam and genomic C. elegans pha-
1(+) gene from the extra-chromosomal array ccEx3994.
Line PD3994 was established by microinjection of plas-
mids pPD176.59 (Lig6649) and pC1(FD142), which con-
tains the C. elegans genomic pha-1 gene [29] and is a
selection marker for ccEx3994. pPD176.59 contains the
E. coli dam gene driven by the myo-3 promoter and a
single SV40 nuclear localization signal.
PD3995 [pha-1(e2123ts)I I I ;ccEx3995]: transgenic
line expressing E. coli dam and genomic C. elegans pha-
1(+) gene from the extra-chromosomal array ccEx3995.
Line PD3995 was generated by microinjection of a mix-
ture of plasmids L7710, pRF4 (carrying the C. elegans
rol-6[su1006] [41]), and pC1 into pha-1(e2123ts)a n i -
mals. Plasmid L7710 contains the rol-6 promoter [42]
driving the expression of a GFP-DAM translational
fusion (rol-6::gfp-dam-unc-54 3′ UTR). Attached to the
3′ end of L7710 is the unc-54 3′ UTR [28].
PD3997[pha-1(e2123ts) III; ccEx3997]: transgenic
line expressing E. coli dam and genomic C. elegans pha-
1(+) gene from the extra-chromosomal array ccEx3997.
Line PD3997 was established by microinjection of a
mixture of plasmids consisting of pC1, pRF4, and L7715
(vit-2::gfp-dam-unc-54 3′ UTR).
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Southern hybridizations were performed according to
standard protocols. Briefly, RNase A-treated genomic
DNA was subjected to one hour restriction digest by
Dpn I, Mbo I,o rSau3A I, followed by phenol:chloro-
form extraction and ethanol precipitation. Restricted
fragments were resolved on 1.4% agarose gels followed
by transfer to Hybond-N+ membranes (Amersham Bios-
ciences, Cat #RPN303B as recommended for capillary
blotting under alkali conditions). An 808 bp radiolabeled
probe containing the C. elegans 5S rDNA/SL1 (Spliced
Leader sequence 1) was synthesized from a Bam H1frag-
ment of plasmid pPD98.38 using the RadPrime DNA
Labeling System (Invitrogen, Cat #18428-11) with
labeled a-
32P dATP (MP Biomedicals, Cat #33002HD.5).
Pre-hybridization and hybridization were in roller bot-
tles using phosphate-SDS buffer (0.5 M phosphate buf-
fer pH7.2, 1 mM EDTA pH8.0, 7% (w/v) SDS, 1% (w/v)
BSA).
DNA extraction from synchronized animal populations
To generate synchronized worm populations, embryos
were collected by treating gravid animals with a solution
containing 1 M NaOH in 10% bleach for approximately
5-7 minutes or until adult cuticles were completely dis-
integrated [39]. Eggs were washed several times with
M9 medium (22 mM KH2PO4,4 2m MN a 2HPO4,8 6
mM NaCl, 1 mM MgSO4) and distributed onto NGM
plates containing a thin layer of SCS110 E. coli seeded
the previous night. Synchronized populations were col-
l e c t e da tt h es t a g ew h e r et h ed e s i r e dt i s s u em a s sw o u l d
be greatest per animal (L1/L2 larvae for the myo-3 pro-
m o t e ri nl i n eP D 3 9 9 4 ;L 4l a r v a ef o rt h erol-6 promoter
in line PD3995; and young/gravid adults for the vit-2
promoter in line PD3997). At no time were synchro-
nized animals starved.
Synchronized animals werew a s h e do f fN G Mp l a t e s
with chilled M9 medium, layered on a 5% sucrose solu-
tion, and pelleted by centrifugation at low speed. Pel-
leted animals were washed several times with chilled
M9 and frozen as ~50 μL pellets at -80°C. It is impor-
tant to note that throughout the harvesting procedure,
animals were alive up to the time before freezing.
Genomic DNA was extracted using the following pro-
cedure. To each thawed ≈50 μl pellet was added 450 μl
worm lysis buffer (0.1 M Tris pH 8.5, 0.1 M NaCl,
50 mM EDTA, 1% SDS), 1 μl 10 mg/ml glycogen, and
20 μL 20 mg/ml proteinase K in TE pH 7.4. The mix-
ture was incubated at 62°C for 45 minutes, with inter-
mittent vortexing. The mixture was extracted with 500
μl phenol, followed by 500 μl phenol:chloroform (1:1),
and 500 μl chloroform. DNA was precipitated with
20 μl saturated ammonium acetate and 1 ml 100% etha-
nol, washed once with 500 μl ethanol, and resuspended
in 50 μlT Ep H7 . 4 .E a c h5 0μl sample was treated with
1 μl 10 mg/ml RNase A for one hour at 37°C. The reac-
tion was terminated with 1× STOP buffer (1 M NH4Ac,
10 mM EDTA, 0.2% SDS) followed by phenol:chloro-
form/chloroform extraction and 100% ethanol precipita-
tion. The final product was resuspended in 40-50 μlT E
and used for DALEC library preparation.
in vitro methylation of N2 genomic DNA
N2 genomic DNA was methylated using the following
200 μl reaction mixture: 30.0 μl( ≈20-30 μg) N2 geno-
mic DNA, 0.5 μl3 2m MS - a d e n o s y lm e t h i o n i n e ,1 . 0μl
E. coli DAM (8 U/μl, NEB M0222S), 20.0 μl1 0 ×D A M
buffer, 148.5 μld H 2O. Following one hour incubation at
37°C, the reaction was terminated with 1× STOP buffer.
To the terminated reaction mixture was added 1 μl1 0
mg/ml glycogen followed by 500 μl phenol:chloroform
extraction, 500 μl chloroform extraction, 100% ethanol
precipitation, 0.5 ml 100% ethanol wash.
Dpn I digestion
Dpn I digestion was carried out in a 200 μl volume con-
sisting of the following mix: 30 μl( ≈20-30 μg) genomic
DNA, 20 μl 10× buffer (NEB4), 10 μl Dpn I (20 U/μl,
NEB #R0176), and 140 μld H 2O. The reaction mix was
incubated for 1.5 hours at 37°C and terminated with
350 μl1 ×S T O Pb u f f e r .1 . 0μl 10 mg/ml glycogen was
added to the mix followed by 500 μl phenol:chloroform
extraction, 500 μl chloroform extraction, precipitation
with 100% ethanol, wash with 0.5 ml 100% ethanol, and
resuspension in 10 μl TE. (NOTE: Unless otherwise
indicated, all enzymatic reactions described below used
the same termination, extraction, and precipitation
steps).
Ligation to Linker A
Linker A was purchased as two separate oligonucleo-
tides (5′OH-CAAGCAGAAGACGGCATACGATCCT-
GAGTACACTATGTTCCGAC-OH3′,5 ′P-GTCGGA
ACATAGTGTAGCA-OH3′) and hybridized by boiling
in a flask of water for five minutes and allowing the
water to cool to room temperature. Ligation to Linker A
was carried out in a 50 μl reaction using the following
mix: 10 μl Dpn I product, 1.5 μlo f0 . 0 5m ML i n k e rA ,
11.0 μld H 2O, 25.0 μl2 ×Q u i c kL i g a s eB u f f e r ,2 . 5μl
Quick Ligase (NEB #M2200). The reaction was incu-
bated for five minutes at room temperature followed by
termination, extraction, precipitation, and resuspension
of ligated products in 10 μl TE.
To increase the number of ligated molecules, we
added a second ligation step using the following mix:
10 μl Quick Ligase product, 7 μld H 2O, 2 μl 10× ligase
buffer, 1 μl T4 DNA ligase (2,000 U/μl; NEB #M0202).
The reaction was allowed to proceed for 30 minutes at
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precipitation, and resuspension in 20 μl TE.
Mme I digestion
Linker A-ligated molecules were subjected to Mme I
digestion using the following 200 μl reaction mix: 20 μl
Linker A-ligated product, 20.0 μl 10× NEB 4, 0.3 μl3 2
mM S-adenosyl methionine, 2.0 μl Mme I (2 U/μl; NEB
R0637), 157.7 μld H 2O. The reaction was allowed to
proceed for 1 hour at 37°C followed by termination,
extraction, precipitation, and resuspension in 10 μl TE.
Ligation to Linker B
Linker B was purchased as two separate oligonucleotides
(5′P-AGATCGGAAGAGCGTCGTGTAGGGAAAG
AGTGTCGGTGGTCGCCGTATCATT-OH3′,5 ′OH-
TCATCTTTCCCTACACGACGCTCTTCCGATCTNN-
OH3′) and hybridized using the same procedure as
described for Linker A. Mme I products were ligated to
Linker B using the following 50 μl reaction mix: 10.0 μl
Mme I product, 1.0 μl of 0.05 mM Linker B, 5.0 μl1 0 ×
ligase buffer, 3.0 μl T4 DNA ligase (2,000 U/μl; NEB
#M0202), 31.0 μld H 2O. Ligations were performed over-
night using a PCR machine. Reactions were initiated at
8°C and stepped up to 16°C, with each degree increase
in temperature held for two hours. Ligated products
were extracted, precipitated, and resuspended in
10 μl TE.
Size selection
Linker A and Linker B ligated molecules were size frac-
tionated on a 6% polyacrylamide:formamide denaturing
gel (15% v/v 19:1 acrylamide:bis (40%), 1× TBE, 25%
(v/v) 100% formamide, 42% w/v urea). Electrophoresis
was performed in 0.5× TBE at 700 V for approximately
2.5-3 hours. The 116 nt single-stranded DNA product
was cut out from the denaturing gel, using single-
stranded oligonucleotides of sizes 95, 105, 114, 116, and
125 as size guides. Products were passively eluted from
excised bands overnight in 0.3 M NaCl at 4°C, precipi-
tated in 100% ethanol, and resuspended in 20 μl TE.
PCR amplification
PCR reactions were performed in a 50 μl reaction con-
sisting of the following mix: 5 μl PAGE-purified tem-
plate, 1.0 μl each of Solexa bridge amplification primers
(1 μg/μl), 5 μl dNTP mix (2 mM each), 5 μl 10× NEB
ThermoPol PCR buffer, 1 μl Taq polymerase (5 U/μl;
NEB M0267), 32 μld H 2O. Reaction cycles were titrated
to determine the linear range, typically 11-17 cycles of
45 s at 94°C, 30 s at 55°C, and 30 s at 72°C, with an
initial denaturation step of 60 s at 94°C and a final
extension step of 60 s at 72°C. PCR products were sepa-
rated on 3% low melting point agarose gel (NuSieve Cat
#50084). For a gel of approximately 10 inches long, elec-
trophoresis at 103 V for approximately six hours gave
superior resolution. The desired 116 bp dsDNA product
was excised and recovered from the gel using the fol-
lowing steps. To each cut band was added 400 μl1 ×
STOP buffer, 1 μl glycogen and incubated in a 68°C
water bath until the agarose was completely melted. To
each tube of melted agarose was added 350 μlo f6 8 ° C
phenol, quickly vortexed, spun 5-7 minutes, and the
aqueous phase extracted (typically, a second 1-2 minute
spin was required to completely remove residual agar-
ose). Following extraction with 250 μl 1:1 phenol:chloro-
form and 250 μl chloroform, DNA was precipitated in
1 ml 100% ethanol, washed with 0.5 ml 100% ethanol,
and resuspended in 15 μl TE for each 5 μl PCR template
used.
Sequencing
Sanger sequencing was performed by Elim Biopharma-
ceuticals Inc. (Hayward, CA). High throughput sequen-
cing of captured DAM tags was performed on the
Solexa Genome Analyzer I.
in silico identification of DAM tags
We generated a database of all potential DAM tags with
the structure 5′-(N)16GATC-3′ from C. elegans genome
version WS170. There are 269,049 DAM (GATC) sites
per haploid genome in C. elegans.B e c a u s eD A L E Cc a p -
tures two tags (in principle) per GATC site, there are a
total of 538,098 potential tags (or half sites) per haploid
genome. To reduce computation time during alignment
of Solexa reads to the genome, each tag was represented
b ya1 6n u c l e o t i d es e q u e n c et h a td i dn o ti n c l u d et h e3 ′
GATC.
We excluded DAM tags that occurred more than
once in the genome or that mapped to vector or ribo-
s o m a ls e q u e n c e s .W ea l s oe x c l u d e dt a g sb e l o n g i n gt o
two adjacent GATC sites that lie within 20 bp from
each other. Under situations where two fully methy-
lated adjacent GATC sites mapped within 20 bp of
each other, one site will always be captured at the
expense of the other, resulting in undercount of DAM
accessibility at such regions. When the distances are
slightly above 20 bp, it is conceivable that there may
be inherent bias in Mme I sequence preference that
leads to the preferential capture of one site over the
other, again resulting in undercount. To avoid both
situations from skewing our analysis, we excluded such
“proximal tags” using the criteria described in Addi-
tional File 2, Figure S4). After filtering out proximal,
repetitive, and vector/ribosome-derived sequences, we
were left with 370,152 in silico tags (per haploid gen-
ome) that we could use to align Solexa reads to the
genome.
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SAGE data were obtained from the Genome BC C. ele-
gans Gene Expression Consortium at http://elegans.
bcgsc.bc.ca/[43]. We downloaded the March 2006 C.
elegans SAGE database using the following relatively
standard parameters: Quality filter: 0.99, Hide ambigu-
ous tags: ON, Tag mapping resources: CODING, show
only mapped tags: ON, Tags/page: 10, Lowest count
cutoff: 1, Hide antisense tags: ON, Remove duplicate
ditags: ON, Highest count cutoff: NONE, Sort order:
DOWN, Resolve lowest match: ON. We used only long
SAGE tags (17 nucleotides long) in our analysis. To
determine a total SAGE score for each gene, we col-
lapsed redundant annotations for each gene to a single
copy and summed the SAGE score for each annotation.
After our filtering criteria, we were left with 13,916
unique genes in our SAGE data set.
All data sets, including raw and aligned Solexa reads,
SAGE data sets, in silico generated Dam tags, and gene
sets used in our analyses have been deposited into GEO
with accession number GSE23042.
Additional material
Additional file 1: Sequence of plasmid pPD177.01 in Microsoft
Word format.
Additional file 2: Supplemental materials, including notes on
methods and supplemental figures and tables in Microsoft Word
format.
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